Avenue Biosciences
Helsinki, FI · Founded 2023 · 23 employees on LinkedIn · 3 known investors
Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.
Founders & leadership
Avenue Biosciences was founded in 2023 by Ville Paavilainen.
VP
Ville PaavilainenCo-founder & Research Director
A
AlastaloMD, PhD
R
RostiPhD, eMBA
Investors · 3
Frequently asked questions
- What does Avenue Biosciences do?
- Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry. The company combines high-throughput chemistry with computational tools to overcome production barriers in protein drug development.
- Who founded Avenue Biosciences?
- Avenue Biosciences was founded by Ville Paavilainen in 2023.
- Who are Avenue Biosciences's investors?
- Avenue Biosciences's investors include Balnord Sp. z o.o., Inventure, Voima Ventures.
- Where is Avenue Biosciences headquartered?
- Avenue Biosciences is headquartered in Helsinki, FI.